Grunenthal

Grunenthal is a global pharmaceutical company headquartered in Aachen, Germany. Founded in 1946, the company initially focused on antibiotics and later expanded its research and development to other therapeutic areas. Grűnenthal's core business revolves around the discovery, development, manufacturing, and marketing of prescription drugs.

The company's primary therapeutic focus is on pain management and inflammation. Grűnenthal has developed and commercialized several notable pain medications. Beyond pain, the company also invests in research for other conditions such as osteoarthritis and women's health. Grűnenthal operates through a network of subsidiaries and partners in numerous countries worldwide.

Innovation is a key driver for Grűnenthal, with a significant portion of its revenue reinvested into research and development. The company aims to address unmet medical needs through scientific advancement. Grűnenthal is a privately held, family-owned company. Its global presence allows it to serve patients and healthcare professionals across various international markets, contributing to the pharmaceutical landscape with its specialized drug portfolio.